Skip to menu Skip to content Skip to footer
Professor Andreas Obermair
Professor

Andreas Obermair

Email: 
Phone: 
+61 7 334 66044

Overview

Background

Professor Obermair is the Director of Queensland Centre for Gynaecological Cancer Research (QCGC Research). He is a Professor of Gynaecological Oncology since 2007, a Senior Medical Officer at Royal Brisbane & Women’s Hospital and a Visiting Medical Officer at St Andrews War Memorial Hospital and Buderim Private Hospital. He holds an Honorary title of Professor at UQ since 2006.

Professor Obermair is an internationally recognised leader in gynaecological oncology research and treatment and has lead the research team at QCGC Research since establishing it in 2003.

Availability

Professor Andreas Obermair is:
Available for supervision

Qualifications

  • Doctoral Diploma of Medicine, International University Vienna
  • Royal Australian and New Zealand College of Obstetricians and Gynaecologists, Royal Australian and New Zealand College of Obstetricians and Gynaecologists

Research interests

  • Clinical Trials

    Decisions on cancer management ideally are based on the results of high-level evidence, obtained through clinical trials whenever possible. As a principle, a new (proposed better) intervention should be compared to the current standard treatment before being made available generally. Outside a clinical trial new treatments should not become available until evidence has become available to demonstrate superiority over the current standard treatment. Retrospective studies harbour the risk that biases influenced outcomes. At QCGC Research we engage in phase 2 and 3 clinical trials. In large phase trials, patients are allocated randomly to one of two or more interventions in order to minimise the risk of bias. Generally, patients treated within clinical trials have a better outcome compared to patients who are not treated in clinical trials. As the Director of Research Gynaecological Oncology I am currently involved in developing and managing clinical trials in gynaecological cancers.

  • Translational Research

    The focus of QCGC Research's translational research program is the application of new technology (molecular, biochemical, imaging and surgical) to prevention, detection and therapy for gynaecological cancers.

  • Quality of Life Research

    Cancer specialists are aware that not only the survival time but also the quality of life is a key factor in cancer treatment. This is especially important when two treatments are equally effective but cause different side-effects. My Quality-of-Life research focuses on ovarian, endometrial, cervical and vulval cancer. I wish to provide the best, most effective and modern treatment to my patients with least possible detriments to quality of life.

  • Minimally Invasive Surgery

    In Australia, around 30,000 hysterectomies are conducted annually to treat uterine cancer and various benign gynaecological conditions. While open abdominal surgery may be necessary in around 10% of cases, evidence shows that less-invasive approaches, such as total laparoscopic hysterectomy (TLH) can achieve better outcomes for women at a lower overall cost to the health system. Yet, in Queensland, four of ten hysterectomies are still conducted by open abdominal surgery. Our own research has shown that many Australian surgeons are keen to adopt new techniques such as TLH, but that the lack of systematic training and mentoring opportunities is the main impediment to practice-change. Together with gynaecological surgical teams at hospitals and industry support we developed a prototype for system-level transformative practice change in gynaecological surgery.

Research impacts

Professor Obermair is an innovative and skilled gynaecologic oncologist, surgical teacher and consumer advocate. His international leadership and research impact was acknowledged in 2020 by the Australian community, when he was awarded an NHMRC Investigator Fellowship Level 2 (2021-25). The national impact of his research was recognised in 2017, when he was awarded Cancer Australia’s Jeannie Ferris Recognition Award (2017), for outstanding achievements in clinical practice and research. He is deeply engaged in consumer involvement and co-founded and serves on the Board of the Cherish Foundation, a consumer-focussed organisation that funds clinical research in better treatments for women with gynaecological cancers.

Works

Search Professor Andreas Obermair’s works on UQ eSpace

360 works between 1991 and 2025

101 - 120 of 360 works

2018

Conference Publication

Achieving healthy weight after endometrial cancer surgery-10-year follow-up of the Laparoscopic Approach to Cancer of the Endometrium (LACE) trial

Obermair, A., Armfield, N. R., Forder, P. and Janda, M. (2018). Achieving healthy weight after endometrial cancer surgery-10-year follow-up of the Laparoscopic Approach to Cancer of the Endometrium (LACE) trial. State of the Art Conference of the European Society of Gynaecological Oncology, Lyon, France, 4-6 October 2018. London, United Kingdom: BMJ Group.

Achieving healthy weight after endometrial cancer surgery-10-year follow-up of the Laparoscopic Approach to Cancer of the Endometrium (LACE) trial

2018

Journal Article

BRAF mutations in low-grade serous ovarian cancer and response to BRAF inhibition

Moujaber, Tania, Etemadmoghadam, Dariush, Kennedy, Catherine J., Chiew, Yoke-Eng, Balleine, Rosemary L., Saunders, Catherine, Wain, Gerard V., Gao, Bo, Hogg, Russell, Srirangan, Sivatharsny, Kan, Casina, Fereday, Sian, Traficante, Nadia, Patch, Ann-Marie, Pearson, John V., Waddell, Nicola, Grimmond, Sean M., Dobrovic, Alexander, Bowtell, David D.L., Harnett, Paul R., deFazio, Anna, Bowtell, D., Chenevix-Trench, G., Green, A., Webb, P., DeFazio, A., Gertig, D., Traficante, N., Fereday, S. ... Zeps, N. (2018). BRAF mutations in low-grade serous ovarian cancer and response to BRAF inhibition. JCO Precision Oncology, 2 (2), 1-14. doi: 10.1200/PO.17.00221

BRAF mutations in low-grade serous ovarian cancer and response to BRAF inhibition

2017

Journal Article

ER and PR expression and survival after endometrial cancer

Smith, Deborah, Stewart, Colin J. R., Clarke, Edward M., Lose, Felicity, Davies, Claire, Armes, Jane, Obermair, Andreas, Brennan, Donal, Webb, Penelope M., Nagle, Christina M. and Spurdle, Amanda B. (2017). ER and PR expression and survival after endometrial cancer. Gynecologic Oncology, 148 (2), 258-266. doi: 10.1016/j.ygyno.2017.11.027

ER and PR expression and survival after endometrial cancer

2017

Journal Article

The relative risk of second primary cancers in Austria's western states: a retrospective cohort study

Preyer, Oliver, Concin, Nicole, Obermair, Andreas, Concin, Hans, Ulmer, Hanno and Oberaigner, Willi (2017). The relative risk of second primary cancers in Austria's western states: a retrospective cohort study. BMC cancer, 17 (1) 699, 699. doi: 10.1186/s12885-017-3683-9

The relative risk of second primary cancers in Austria's western states: a retrospective cohort study

2017

Journal Article

Factors influencing women's decision making in hysterectomy

Janda, Monika, Armfield, Nigel R., Page, Katie, Kerr, Gayle, Kurz, Suzanne, Jackson, Graeme, Currie, Jason, Weaver, Edward, Yazdani, Anusch and Obermair, Andreas (2017). Factors influencing women's decision making in hysterectomy. Patient Education and Counseling, 101 (3), 504-510. doi: 10.1016/j.pec.2017.09.006

Factors influencing women's decision making in hysterectomy

2017

Journal Article

Family history of cancer predicts endometrial cancer risk independently of Lynch Syndrome: implications for genetic counselling

Johnatty, Sharon E., Tan, Yen Y., Buchanan, Daniel D., Bowman, Michael, Walters, Rhiannon J., Obermair, Andreas, Quinn, Michael A., Blomfield, Penelope B., Brand, Alison, Leung, Yee, Oehler, Martin K., ANECS Group, Kirk, Judy A., O'Mara, Tracy A., Webb, Penelope M. and Spurdle, Amanda B. (2017). Family history of cancer predicts endometrial cancer risk independently of Lynch Syndrome: implications for genetic counselling. Gynecologic Oncology, 147 (2), 381-387. doi: 10.1016/j.ygyno.2017.08.011

Family history of cancer predicts endometrial cancer risk independently of Lynch Syndrome: implications for genetic counselling

2017

Journal Article

Survival after laparoscopic vs abdominal hysterectomy - reply

Gebski, Val, Janda, Monika and Obermair, Andreas (2017). Survival after laparoscopic vs abdominal hysterectomy - reply. Journal of the American Medical Association, 318 (6), 574-575. doi: 10.1001/jama.2017.8161

Survival after laparoscopic vs abdominal hysterectomy - reply

2017

Journal Article

The shift toward neo-adjuvant chemotherapy and interval debulking surgery for management of advanced ovarian and related cancers in a population-based setting: Impact on clinical outcomes

Nicklin, James L., McGrath, Shaun, Tripcony, Lee, Garrett, Andrea, Land, Russell, Tang, Amy, Perrin, Lewis, Chetty, Naven, Jagasia, Nisha, Crandon, Alex J., Nascimento, Marcelo, Walker, Graeme, Sanday, Karen and Obermair, Andreas (2017). The shift toward neo-adjuvant chemotherapy and interval debulking surgery for management of advanced ovarian and related cancers in a population-based setting: Impact on clinical outcomes. Australian & New Zealand Journal of Obstetrics and Gynaecology, 57 (6), 651-658. doi: 10.1111/ajo.12665

The shift toward neo-adjuvant chemotherapy and interval debulking surgery for management of advanced ovarian and related cancers in a population-based setting: Impact on clinical outcomes

2017

Journal Article

Lymphedema following gynecological cancer: results from a prospective, longitudinal cohort study on prevalence, incidence and risk factors

Hayes, Sandra C., Janda, Monika, Ward, Leigh C., Reul-Hirche, Hildegard, Steele, Megan L., Carter, Johnathan, Quinn, Michael, Cornish, Bruce and Obermair, Andreas (2017). Lymphedema following gynecological cancer: results from a prospective, longitudinal cohort study on prevalence, incidence and risk factors. Gynecologic Oncology, 146 (3), 623-629. doi: 10.1016/j.ygyno.2017.06.004

Lymphedema following gynecological cancer: results from a prospective, longitudinal cohort study on prevalence, incidence and risk factors

2017

Journal Article

Effect of Total Laparoscopic Hysterectomy vs Total Abdominal Hysterectomy on Disease-Free Survival Among Women With Stage I Endometrial Cancer A Randomized Clinical Trial

Janda, Monika, Gebski, Val, Davies, Lucy C., Forder, Peta, Brand, Alison, Hogg, Russell, Jobling, Thomas W., Land, Russell, Manolitsas, Tom, Nascimento, Marcelo, Neesham, Deborah, Nicklin, James L., Oehler, Martin K., Otton, Geoff, Perrin, Lewis, Salfinger, Stuart, Hammond, Ian, Leung, Yee, Sykes, Peter, Ngan, Hextan, Garrett, Andrea, Laney, Michael, Ng, Tong Yow, Tam, Karfai, Chan, Karen, Wrede, C. David, Pather, Selvan, Simcock, Bryony, Farrell, Rhonda ... Obermair, Andreas (2017). Effect of Total Laparoscopic Hysterectomy vs Total Abdominal Hysterectomy on Disease-Free Survival Among Women With Stage I Endometrial Cancer A Randomized Clinical Trial. Jama-Journal of the American Medical Association, 317 (12), 1224-1233. doi: 10.1001/jama.2017.2068

Effect of Total Laparoscopic Hysterectomy vs Total Abdominal Hysterectomy on Disease-Free Survival Among Women With Stage I Endometrial Cancer A Randomized Clinical Trial

2017

Journal Article

Nutrition interventions in patients with gynecological cancers requiring surgery

Obermair, Andreas, Simunovic, Marko, Isenring, Liz and Janda, Monika (2017). Nutrition interventions in patients with gynecological cancers requiring surgery. Gynecologic Oncology, 145 (1), 192-199. doi: 10.1016/j.ygyno.2017.01.028

Nutrition interventions in patients with gynecological cancers requiring surgery

2017

Journal Article

Do breast cancer survivors benefit from prophylactic removal of uterus and ovaries? A population-based data linkage replication study

Obermair, Andreas, Youlden, Danny, Baade, Peter and Janda, Monika (2017). Do breast cancer survivors benefit from prophylactic removal of uterus and ovaries? A population-based data linkage replication study. Asia-Pacific Journal of Clinical Oncology, 13 (1), 68-78. doi: 10.1111/ajco.12508

Do breast cancer survivors benefit from prophylactic removal of uterus and ovaries? A population-based data linkage replication study

2017

Conference Publication

The association of lymphedema trajectories with symptoms and symptom severity following gynaecological cancer treatment in Queensland: a prospective cohort study

Obermair, A., Fleming, S., Hayes, S., Ward, L., Kneul-Hirche, H. and Janda, M. (2017). The association of lymphedema trajectories with symptoms and symptom severity following gynaecological cancer treatment in Queensland: a prospective cohort study. ESGO 20: European Gynaecological Oncology Congress 2017, Vienna, Austria, 4-7 November 2017. London, United Kingdom: Lippincott Williams & Wilkins.

The association of lymphedema trajectories with symptoms and symptom severity following gynaecological cancer treatment in Queensland: a prospective cohort study

2016

Journal Article

Real-world surgical outcomes of a gelatin-hemostatic matrix in women requiring a hysterectomy: a matched case–control study

Obermair, Helena, Janda, Monika and Obermair, Andreas (2016). Real-world surgical outcomes of a gelatin-hemostatic matrix in women requiring a hysterectomy: a matched case–control study. Acta Obstetricia et Gynecologica Scandinavica, 95 (9), 1008-1014. doi: 10.1111/aogs.12924

Real-world surgical outcomes of a gelatin-hemostatic matrix in women requiring a hysterectomy: a matched case–control study

2016

Journal Article

Cost-efficiency of robotic surgery

Covens, Al, Köhler, Christhardt, Nam, Joo-Hyun, Naumann, R. Wendel, Obermair, Andreas and Querleu, Denis (2016). Cost-efficiency of robotic surgery. International Journal of Gynecological Cancer, 26 (6), 992-993. doi: 10.1097/IGC.0000000000000747

Cost-efficiency of robotic surgery

2016

Journal Article

Surgical safety and personal costs in morbidly obese, multimorbid patients diagnosed with early-stage endometrial cancer having a hysterectomy

Obermair, Andreas, Brennan, Donal J., Baxter, Eva, Armes, Jane E., Gebski, Val and Janda, Monika (2016). Surgical safety and personal costs in morbidly obese, multimorbid patients diagnosed with early-stage endometrial cancer having a hysterectomy. Gynecologic Oncology Research and Practice, 3 (1), 1. doi: 10.1186/s40661-016-0023-8

Surgical safety and personal costs in morbidly obese, multimorbid patients diagnosed with early-stage endometrial cancer having a hysterectomy

2016

Conference Publication

Disease-free and overall-survival after total laparoscopy versus open abdominal hysterectomy for early stage endometrial cancer: results from the lace trial

Obermair, A., Gebski, V., Davies, L., Brand, A., Hogg, R., Jobling, T. W., Land, R., Manolitsas, T., Nascimento, M., Neesham, D., Nicklin, J. L., Oehler, M. K., Otton, G., Perrin, L., Salfinger, S., Hammond, I., Leung, Y., Sykes, P., Ngan, H., Garrett, A., Forder, P., Laney, M., Ng, T. Y., Tam, K., Chan, K., Wrede, D. H., Pather, S., Simcock, B., Farrell, R. ... Janda, M. (2016). Disease-free and overall-survival after total laparoscopy versus open abdominal hysterectomy for early stage endometrial cancer: results from the lace trial. Unknown, Unknown, Unknown. London, United Kingdom: Lippincott Williams & Wilkins.

Disease-free and overall-survival after total laparoscopy versus open abdominal hysterectomy for early stage endometrial cancer: results from the lace trial

2015

Journal Article

Consideration for safe and effective gynaecological laparoscopy in the obese patient

Hackethal, A., Brennan, D., Rao, A., Land, R., Obermair, A., Nicklin, J., Garrett, A., Nascimento, M., Crandon, A., Perrin, L. and Chetty, N. (2015). Consideration for safe and effective gynaecological laparoscopy in the obese patient. Archives of Gynecology and Obstetrics, 292 (1), 135-141. doi: 10.1007/s00404-014-3600-2

Consideration for safe and effective gynaecological laparoscopy in the obese patient

2015

Journal Article

Quality of life after early enteral feeding versus standard care for proven or suspected advanced epithelial ovarian cancer: Results from a randomised trial

Baker, Jannah, Janda, Monika, Graves, Nick, Bauer, Judy, Banks, Merrilyn, Garrett, Andrea, Chetty, Naven, Crandon, Alex J, Land, Russell, Nascimento, Marcelo, Nicklin, James L, Perrin, Lewis C and Obermair, Andreas (2015). Quality of life after early enteral feeding versus standard care for proven or suspected advanced epithelial ovarian cancer: Results from a randomised trial. Gynecologic Oncology, 137 (3), 516-522. doi: 10.1016/j.ygyno.2015.03.048

Quality of life after early enteral feeding versus standard care for proven or suspected advanced epithelial ovarian cancer: Results from a randomised trial

2015

Journal Article

Lower preoperative quality of life increases postoperative risk of adverse events in women with endometrial cancer: results from the LACE trial

Baker, Jannah, Janda, Monika, Gebski, Val, Forder, Peta, Hogg, Russell, Manolitsas, Tom and Obermair, Andreas (2015). Lower preoperative quality of life increases postoperative risk of adverse events in women with endometrial cancer: results from the LACE trial. Gynecologic Oncology, 137 (1), 102-105. doi: 10.1016/j.ygyno.2015.02.008

Lower preoperative quality of life increases postoperative risk of adverse events in women with endometrial cancer: results from the LACE trial

Funding

Current funding

  • 2026 - 2030
    Towards evidence-supported precision surgery for gynaecological cancer
    NHMRC Investigator Grants
    Open grant
  • 2025 - 2030
    Centre of Research Excellence to Improve the QuALIty of SurVival in Gynaecological Cancer PatiEnts (ALIVE WELL)
    NHMRC Centres of Research Excellence
    Open grant
  • 2025 - 2026
    The Australian National Vulvar Cancer (ANVU) trial: A Phase II clinical trial of groin ultrasound surveillance to de-escalate surgical intervention in vulvar cancer
    Cherish Women's Cancer Foundation
    Open grant
  • 2024 - 2029
    The EARLY study: Evaluating the Specificity and feasibility of the EARLY Test for Ovarian Cancer Detetion
    NHMRC Partnership Projects
    Open grant
  • 2024 - 2027
    Moving without fear when living with stoma: A consumer-led physical activity study (MRFF CLR Grant administered by Griffith University)
    Open grant
  • 2024 - 2029
    Salpingectomy with delayed oophorectomy to prevent ovarian cancer (TUBA WISP II) (MRFF ICTC Grant led by University of Melbourne)
    University of Melbourne
    Open grant
  • 2024 - 2025
    EN.10 - A Phase II study of adjuvant therapy in pole-mutated and p53-wildtype/NSWP early stage endometrial cancer (RAINBO BLUE & TAPER)
    Australia New Zealand Gynaecological Oncology Group
    Open grant
  • 2024 - 2025
    Queensland Centre for Gynaecological Cancer's NODE Study
    Gynaecological Cancer Research, Education and Development Society Limited Research Grant
    Open grant
  • 2024 - 2028
    ENDO3:A Phase III Randomised Controlled Clinical Trial Comparing Disease-Free Survival of Patients with or without Lymph Node Dissection in clinical stage I Endometrial Cancer (ANZGOGtrial #1911/2020)
    NHMRC Clinical Trials and Cohort Studies Grants
    Open grant
  • 2024 - 2025
    Feasibility testing Of telehealth-delivered eXercise Therapy for Ostomates Treated for cancer (FOXTROT)
    Wesley Research Institute Ltd
    Open grant
  • 2023 - 2028
    Vulvar Cancer Feasibility Study: Establishing a novel pathway to best-practice treatment in vulvar cancer
    Research Donation Generic
    Open grant
  • 2022 - 2026
    A non-surgical alternative to hysterectomy for the treatment of endometrial cancer
    NHMRC Partnership Projects
    Open grant
  • 2021 - 2025
    Creating treatment options for endometrial cancer through high-level clinical trials
    NHMRC Investigator Grants
    Open grant
  • 2010 - 2025
    QCOG (Data Manager Grant)
    Cancer Council Queensland
    Open grant

Past funding

  • 2024
    Moving without fear when living with stoma: A consumer-led physical activity study
    NHMRC MRFF PPHR - Consumer Led Research
    Open grant
  • 2024
    Improving quality of life for vulvar cancer patients through non-invasive interventions
    Metro North Hospital and Health Service
    Open grant
  • 2021 - 2024
    MOST (Measure of Ovarian Symptoms and Treatment concerns)
    St John of God Healthcare Inc
    Open grant
  • 2020 - 2022
    A Phase III Randomised Clinical Trial Comparing Patient Outcomes of Sentinel Lymph Node Dissection in Endometrial Cancer (ENDO-3PRO trial)
    Cherish Women's Cancer Foundation
    Open grant
  • 2020 - 2024
    A Phase II trial evaluating feasibility, safety and efficacy of an individually-tailored exercise intervention during chemotherapy for recurrent ovarian cancer (MRFF EPCDR administered by Griffith).
    Griffith University
    Open grant
  • 2020 - 2023
    Implementing non-surgical options for endometrial cancer treatment into clinical practice
    ICON Cancer Care
    Open grant
  • 2020 - 2021
    A Phase III Randomised Clinical Trial Comparing Sentinel Node Biopsy with No Retroperitoneal Node Dissection in Early-Stage Endometrial Cancer (ENDO-3)
    Metro North Hospital and Health Service
    Open grant
  • 2019 - 2020
    feMMe Long Term Follow-Up study
    ASGO Research Grants
    Open grant
  • 2019 - 2020
    A Phase III Randomised Clinical Trial Comparing Sentinel Node Biopsy with No Retroperitoneal Node Dissection in Early-Stage Endometrial Cancer (ENDO-3)
    Gynaecological Cancer Research, Education and Development Society Limited Research Grant
    Open grant
  • 2017 - 2020
    The Implementation of MinimAlly INvasivE hysterectomy (IMAGINE) trial
    NHMRC Partnership Projects
    Open grant
  • 2017 - 2018
    Transforming surgical practice through innovation IMAGINE
    Metro North Hospital and Health Service
    Open grant
  • 2017 - 2021
    The ECHO trial: Exercise during CHemotherapy for Ovarian cancer (World Cancer Research Fund International grant administered by QUT)
    Queensland University of Technology
    Open grant
  • 2017 - 2021
    The Ovarian Cancer Prognosis and Lifestyle (OPAL) Study: Long-term outcomes (NHMRC Project Grant administered by QIMR)
    Queensland Institute of Medical Research
    Open grant
  • 2016 - 2018
    Long-term follow-up of the Laparoscopic Approach to Carcinoma of the Endometrium (LACE) Trial - survival outcomes
    Cancer Australia
    Open grant
  • 2016
    QCOG 2016
    Cancer Council Queensland
    Open grant
  • 2015 - 2019
    Cherish women's cancer foundation research fellow funding
    Cherish Women's Cancer Foundation
    Open grant
  • 2015 - 2022
    ECHO trial: Exercise during Chemotherapy for Ovarian cancer (Cancer Australia grant administered by The University of Sydney)
    University of Sydney
    Open grant
  • 2015 - 2018
    The fEMMe trial
    Cancer Australia
    Open grant
  • 2015 - 2016
    In Memory of Denise Marcella Collins
    Research Donation Generic
    Open grant
  • 2015 - 2016
    Impact of gated PET/CT on the diagnosis of distant metastases of advanced epithelial ovarian, fallopian tube, and primary peritoneal cancer
    Royal Brisbane and Women's Hospital
    Open grant
  • 2015 - 2019
    Selective targeting of adjuvant therapy for endometrial cancer: the STATEC trial (NHMRC Project Grant administered by University of Sydney)
    University of Sydney
    Open grant
  • 2014 - 2015
    A Phase II Randomised Clinical Trial of Mirena® ± Metformin ± Weight Loss Intervention in Patients with Early Stage Cancer of the Endometrium
    Royal Brisbane and Women's Hospital Foundation
    Open grant
  • 2014 - 2015
    Barriers of the uptake of laparoscopic hysterectomy
    Australian Centre for Health Services Innovation
    Open grant
  • 2014 - 2015
    A Phase II Randomised Clinical Trial of Mirena® ± Metformin ± Weight Loss Intervention in Patients with Early Stage Cancer of the Endometrium
    Australia New Zealand Gynaecological Oncology Group
    Open grant
  • 2014 - 2015
    Prophylactic surgery and breast cancer
    Royal Brisbane & Women's Hospital Research Foundation
    Open grant
  • 2013 - 2020
    ACRF Molecular Oncology Translational Imaging Facility (MOTIF)
    Australian Cancer Research Foundation
    Open grant
  • 2013 - 2016
    Mirena ±Weight Loss to treat early Endometrial Cancer (MAxWEL Trial - Cancer Australia grant administered by Queensland University of Technology)
    Queensland University of Technology
    Open grant
  • 2013
    A phase II randomised clinical trial of mirena +/- metformin in patients with early stage cancer of the endometrium
    Royal Brisbane and Women's Hospital
    Open grant
  • 2013
    QCOG 2013 (Data Manager Grants)
    Cancer Council Queensland
    Open grant
  • 2012 - 2023
    In Memory of Jan Sanders and other philanthropic donations
    Research Donation Generic
    Open grant
  • 2012 - 2013
    LEGS follow-up: Lymphoedema Evaluation following Gynaecology Cancer Study
    Queensland University of Technology
    Open grant
  • 2012 - 2013
    The effect of prophylactic, risk-reducing gynaecological surgery on survival among patients with a history of breast cancer
    Royal Brisbane and Women's Hospital
    Open grant
  • 2011 - 2012
    HE 4 Collaborative Study
    Abbott Australasia Pty Ltd
    Open grant
  • 2011
    LEGS:Lymphoedema Evaluation in Gynaecological Cancer Study
    Royal Brisbane and Women's Hospital
    Open grant
  • 2011 - 2012
    Postoperative Enteral Nutrition in Patients with Advanced Epithelial Ovarian Cancer
    Wesley Merdical Research
    Open grant
  • 2010 - 2023
    A Phase III Randomized Clinical Trial of Laparoscopic or Robotic Radical Hysterectomy versus Abdominal radical hysterectomy in patients with early stage cervical cancer (Clinical Trial Agreement)
    University of Texas M.D. Anderson Cancer Centre
    Open grant
  • 2010 - 2013
    Laparoscopic Approach to Carcinoma of the Endometrium. An international multicentre randomised Phase 3 clinical trial
    Cancer Australia
    Open grant
  • 2010 - 2013
    Postoperative Enteral Nutrition in Patients with Advanced Epithelial Ovarian Cancer
    Cancer Australia
    Open grant
  • 2009 - 2011
    National Gynaecological Cancers Service Delivery and Resources Framework
    Cancer Australia
    Open grant
  • 2009 - 2012
    Mayne Bequest Fund Research Support Award: Research & development into better standard of care for women experiencing gynaecological cancer
    Mayne Bequest Fund
    Open grant
  • 2009 - 2012
    A Phase III Randomized Clinical Trial of Laparoscopic or Robotic Radical Hysterectomy versus Abdominal Radical Hysterectomy in Patients with Early Stage Cervical Cancer
    University of Texas M.D. Anderson Cancer Centre
    Open grant
  • 2009 - 2010
    Cancer Clinical Trial Data Management Grant 2009
    Cancer Council Queensland
    Open grant
  • 2009 - 2010
    Post-operative enteral nutrition among patients with ovarian cancer
    Gallipoli Research Foundation
    Open grant
  • 2009
    Prognostic value of preoperative CA125 in ovarian tumours of low malignant potential
    Royal Brisbane & Women's Hospital Research Foundation
    Open grant
  • 2009 - 2010
    Prospective evaluation of lymphoedema among patients with gynaecological cancer
    Gallipoli Research Foundation
    Open grant
  • 2008 - 2011
    Prospective evaluation of lymphoedema among patients with gynaecological cancer
    Wesley Merdical Research
    Open grant
  • 2008 - 2011
    Prospective evaluation of lymphoedema among patients with gynaecological cancer
    Cancer Australia
    Open grant
  • 2008 - 2009
    LACE - Laparoscopic Approach to Carcinoma of the Endometrium - An International Multicentre Randomised Phase 3 Clinical Trial
    Royal Brisbane & Women's Hospital Research Foundation
    Open grant
  • 2008
    Cancer Clinical Trial Data Management grant 2008
    Queensland Cancer Fund
    Open grant
  • 2008
    Laparoscopic approach to cervical carcinoma -a phase III randomised clinical trial of laparoscopic radical hysterectomy versus abdominal radical hysterectomy in patients w/ early stage cervical cancer
    Royal Brisbane & Women's Hospital Research Foundation
    Open grant
  • 2007 - 2009
    Total Laparoscopic hysterectomy for Endometrial Cancer
    Queensland Health Smart Health Research Grant
    Open grant
  • 2007
    Cancer Clinical Trial Data Manager, QLD Centre for Gynaecological cancer - 2007
    Queensland Cancer Fund
    Open grant
  • 2007
    LACE- Laparoscopic approach to carcinoma of the endometrium - An international multicentre randomised phase 3 clinical trial - Top-Up funding
    Royal Brisbane & Women's Hospital Research Foundation
    Open grant
  • 2007 - 2009
    Total Laparoscopic Hysterectomy (TLH) vs. Total Abdominal Hysterectomy (TAH) for the Treatment of Endometrial Cancer
    NHMRC Project Grant
    Open grant
  • 2006
    Cancer Clinical Trial Data Manager at the QLD Centre for Gynaecological Cancer
    Queensland Cancer Fund
    Open grant
  • 2006
    LACE - Laparoscopic approach to carinoma of the endometrium - An International Multicentre Randomised Phase 3 Clinical Trial
    Queensland Cancer Fund
    Open grant
  • 2006 - 2007
    Total laparoscopic hysterectomy (TLH) vs Total Abdominal Hysterectomy (TAH) for the treatment of endometrial cancer
    Queensland Cancer Fund
    Open grant
  • 2005 - 2006
    Clinical Trial Data Manager
    Queensland Cancer Fund
    Open grant
  • 2005 - 2006
    Start-up Grant
    Royal Brisbane & Women's Hospital Research Foundation
    Open grant
  • 2004 - 2007
    Gynaecological Cancer Society Research Grants
    Gynaecological Cancer Society
    Open grant
  • 2004
    Mismatch repair gene defects in endometrial cancer patients less than 50 years of age
    Royal Brisbane & Women's Hospital Research Foundation
    Open grant

Supervision

Availability

Professor Andreas Obermair is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Available projects

  • feMMe: Uterus-preserving treatment of endometrial cancer

    In 2020 we completed the feMMe, phase 2 cliniccal trial which established anticancer activity of levonorgestrel intrauterrine device (LNG-IUD) to treat endometrial cancer. The next two steps towards estabnlioshing this treatment for larger groups of patients include:

    1. To determine factors that predict response to LNG-IUD

    2. To determine long-term patient outcomes including survival, fertility, and patient needs.

  • Improving Quality of Survival for Women with Gynaecological Cancer

    • Focus on improving quality of life, health & function during & after gynaecological cancer treatment, with a focus on biomarker research, implementation research and cancer survivorship.

Supervision history

Current supervision

  • Master Philosophy

    Patterns of care in endometrial cancer management in Queensland: a retrospective analysis.

    Principal Advisor

    Other advisors: Dr Eva Baxter

  • Doctor Philosophy

    Advanced methods for biomarker informed endometrial cancer

    Principal Advisor

    Other advisors: Dr Eva Baxter, Dr Zoe West, Professor Andrew Martin

  • Doctor Philosophy

    Diet quality and composition in Australian women with endometrial cancer

    Associate Advisor

    Other advisors: Professor Monika Janda

Completed supervision

Media

Enquiries

For media enquiries about Professor Andreas Obermair's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au